FreeStyle InsuLinx Blood Glucose Monitoring System Receives CE Mark
Approximately 55 million people in Europe are living with diabetes and many require insulin to manage their condition. For people who use insulin, managing diabetes can often involve challenging calculations to determine an appropriate mealtime insulin dose. Individuals soemtimes have trouble with the calculations required for insulin dose adjustment, resulting in insulin dose calculation errors.
Abbott today announced that it has received CE Mark (Conformite Europeenne) for its new FreeStyle InsuLinx Blood Glucose Monitoring System which includes a mealtime (bolus) insulin…